Haohai Biotec shareholder faces regulatory investigation
Shanghai Haohai Biological Technology Co., Ltd. (HKEX: 6826) announced that controlling shareholder Jiang Wei is being investigated by the CSRC for suspected insider trading, as detailed in Notice No.: Zheng Jian Li An Zi 0382025016. The company stated the investigation relates to Mr. Jiang personally and will not materially impact the daily operation of the company. Haohai Biotec assures investors it will continue to comply with disclosure obligations and cooperate with the investigation.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Shanghai Haohai Biological Technology publishes news
Free account required • Unsubscribe anytime